Richmond Pharmacology is a contract research organization (CRO) based in London, United Kingdom. The company specializes in conducting early-phase clinical trials, including Phase I and Phase IIa studies, primarily in healthy volunteers and specific patient populations. It operates a centralized clinical research facility located in central London, near St. Thomas' Hospital and Guy's Hospital, which facilitates access to medical expertise and patient recruitment.
The organization provides services such as trial design, regulatory support, pharmacokinetic and pharmacodynamic assessments, bioanalysis, data management, and medical monitoring. Richmond Pharmacology focuses on first-in-human trials, adaptive study designs, and specialized therapeutic areas including immunology, respiratory diseases, and central nervous system disorders.
Founded in 2001, Richmond Pharmacology positions itself as an independent provider of early clinical development services, working with biotechnology and pharmaceutical companies globally. It emphasizes operational efficiency, regulatory compliance, and the application of biomarker-driven approaches in clinical pharmacology.
The company is registered in England and Wales and operates under applicable regulatory frameworks, including Good Clinical Practice (GCP) guidelines and oversight by the UK Medicines and Healthcare products Regulatory Agency (MHRA).